Vitamin C Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Vitamin C dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Vitamin C.
Dosing Protocols
Beginner Vitamin C Protocol (4-6 weeks):
- Week 1-2: Start with 250 mg ascorbic acid or buffered ascorbate with breakfast. Observe for any GI intolerance.
- Week 3-4: If tolerated, increase to 500 mg daily, either as single dose with breakfast or split 250 mg AM + 250 mg afternoon.
- Week 5-6: Maintain 500 mg daily indefinitely. This is the sweet spot for most adults: above the RDA (providing margin for oxidative stress, occasional illness, and dietary variability) but below the dose where GI effects and diminishing returns emerge.
Starting form recommendation:
- Ascorbic acid capsules/tablets: cheapest, effective, may cause mild GI upset in sensitive individuals
- Sodium ascorbate or buffered (Ester-C, mineral ascorbates): gentler on stomach; small additional cost
- Whole-food vitamin C (acerola cherry, camu camu, rose hips): includes natural cofactors; higher cost per mg but some users prefer
Dietary emphasis alongside supplementation:
- Daily servings of fruits and vegetables: citrus fruits (orange ~70 mg), berries (strawberries 85 mg/cup), kiwi (~90 mg each), peppers (raw red bell pepper 150 mg/cup), broccoli, kale
- Aim for 200 mg/day from food alone; supplementation builds on top of dietary foundation
Stack additions to consider:
- Vitamin D3 2,000-4,000 IU with breakfast (see /compound/vitamin-d)
- Magnesium glycinate 300-400 mg elemental (evening) (see /compound/magnesium)
- Zinc picolinate 15 mg with a meal (see /compound/zinc)
- Omega-3 EPA+DHA 1-2 g (see /compound/omega-3-fatty-acids)
- Vitamin K2 (MK-7) 100 mcg (see /compound/vitamin-k2)
Expected outcomes at beginner level:
- Plasma ascorbate rises to upper-normal range within 1-2 weeks
- Subtle benefits to immune function, skin, gum health; usually no acute subjective effect
- Supports broader antioxidant network
Cost at beginner level: approximately $5-10/month for vitamin C; $20-40 for full foundational stack.
Intermediate Vitamin C Protocol (targeted goals):
For common cold/viral illness prophylaxis in high-stress periods:
- 500 mg with breakfast + 500 mg with lunch (1,000 mg daily) during cold/flu season or high physical stress periods
- At first symptoms: escalate to 2,000 mg daily split across 4 doses of 500 mg
- Continue at 2,000 mg daily for duration of illness plus 2 days after resolution
- Return to 500-1,000 mg maintenance dose
For connective tissue/tendon/ligament support:
- Vitamin C 500 mg + glycine 5 g + hydrolyzed collagen peptides 10-15 g
- Taken 30-60 minutes before weight-bearing or tendon-loading exercise
- Based on Shaw et al.collagen synthesis data
- Continue for 8-12 weeks minimum for injury prevention or rehabilitation support
- See /compound/glycine for additional context
For skin health and collagen maintenance:
- Vitamin C 500-1,000 mg daily
- Plus topical vitamin C serum (15-20% L-ascorbic acid) AM for direct dermal effect
- Plus oral collagen peptides 10-15 g daily
- Plus adequate dietary protein 1.0-1.2 g/kg/day
- Effects on skin quality emerge over 3-6 months
For iron deficiency anemia (adjunct to iron supplementation):
- Ferrous sulfate 65 mg (or equivalent elemental iron 65-130 mg) + vitamin C 100-200 mg with a meal
- Check ferritin and Hgb every 3 months
- Vitamin C enhances absorption; does not replace iron itself
For cardiovascular endothelial support in hypertension/smoking/diabetes:
- Vitamin C 500 mg AM + 500 mg PM (1,000 mg daily split)
- Plus omega-3 EPA+DHA 2-3 g
- Plus magnesium 300-400 mg elemental
- Plus addressing underlying condition with evidence-based therapy
- Expect improvements in flow-mediated dilation markers; event-level benefit unclear
For athletes/heavy training (modest dose to avoid adaptation blunting):
- Vitamin C 200-500 mg daily from diet + modest supplement
- Avoid chronic ≥1 g doses during key training blocks (may blunt mitochondrial adaptation per Ristow/Paulsen)
- Higher doses (1-2 g/day) reserved for acute illness or pre-competition recovery windows, not chronic training
For older adults with reduced intake/absorption:
- Vitamin C 500 mg daily with meal (better absorbed with food)
- Dietary emphasis on daily fruits and vegetables
- Pair with adequate protein, vitamin D, B12 screening
For surgical patients (pre- and post-operative):
- Pre-op (if nutritionally suboptimal): 500-1,000 mg daily for 2 weeks prior
- Post-op: 500-1,000 mg daily for 4-6 weeks to support collagen synthesis and wound healing
- Coordinate with surgical team; most routine surgeries don't require specific protocols but deficient patients benefit
Typical intermediate stack cost: $10-25/month for vitamin C component; $50-100 for full targeted stack including collagen, omega-3, etc.
Advanced Vitamin C Protocol (clinical-condition targeted):
For high-dose oral supplementation (bowel tolerance titration, "Cathcart method"):
- Gradual titration from 500 mg to maximum tolerated dose based on bowel tolerance
- Typical maximum 4-10 g daily in divided doses (every 2-4 hours)
- Used mainly during acute viral illness for symptomatic period; not maintained chronically
- Rationale: plasma ascorbate remains at saturation regardless of additional dose, but tissue saturation and some antioxidant effects may incrementally benefit from high oral intake
- Cautions: GI tolerance, kidney stone risk for chronic high doses, possible exercise adaptation interference
For IV vitamin C (research/integrative oncology context, medical supervision required):
- Typical infusion: 25-75 g over 90-120 minutes in saline
- Pre-screen for G6PD deficiency, renal function, hemochromatosis
- Most common contexts: integrative cancer care (alongside conventional chemotherapy, context-dependent efficacy), chronic fatigue syndromes, post-viral recovery
- Evidence base mixed; not standard-of-care in most conventional oncology
- Coordinate with oncology or internal medicine
- Patients should NOT self-administer IV vitamin C; requires medical setting
For suspected or confirmed subclinical vitamin C deficiency:
- Oral ascorbic acid 500-1,000 mg BID for 4-6 weeks
- Optimize diet simultaneously (daily fruits/vegetables)
- Recheck plasma ascorbate if measured; symptoms (fatigue, easy bruising, gum bleeding, poor wound healing) should improve within 2-4 weeks
For wound-healing support in complex wounds or burn patients (hospital or specialist-supervised):
- Oral or IV ascorbic acid 1-2 g daily during active healing phase
- Combined with adequate protein, zinc, vitamin A, and other nutrients
- Often part of institutional nutrition support protocols
For glaucoma (investigational; under ophthalmology direction):
- Vitamin C 500 mg BID with ophthalmology monitoring
- Evidence is preliminary; not standard glaucoma management
For age-related macular degeneration (intermediate or late AMD):
- AREDS2 formula: vitamin C 500 mg + vitamin E 400 IU + lutein 10 mg + zeaxanthin 2 mg + zinc 25-80 mg + copper 2 mg
- Under ophthalmology management
- Evidence: AREDS and AREDS2 trials demonstrate slowing of AMD progression in moderate-severe disease
For chronic urinary tract infection / biofilm disruption (integrative/alternative):
- Vitamin C 500 mg QID with focus on urine acidification
- Evidence weaker than targeted antibiotics; mechanism via acidification and direct antibacterial action at high urinary concentrations
- Can complement standard therapy; not replacement
For chronic stress, HPA-axis support:
- Vitamin C 500-1,000 mg daily (adrenal cortex concentrates ascorbate and depletes during stress)
- Combined with adequate sleep, stress management, adaptogens if desired
- Rationale mechanistic; evidence for specific cortisol-modulating effects of vitamin C is modest
Biomarker-guided titration (research-grade approach):
- Baseline plasma ascorbate (reference range 23-114 μmol/L; optimal >50 μmol/L)
- Goal: maintain >60-80 μmol/L
- Most healthy adults on 500-1,000 mg/day supplementation achieve this
- Smokers, critically ill patients, and those with malabsorption may require higher intakes for similar plasma levels
Monitoring at advanced level:
- Every 3-6 months: CBC, CMP (including creatinine for renal function), possibly plasma ascorbate
- Annual: consider 24-hour urinary oxalate if chronic high-dose supplementation in someone at stone risk
- Any new symptoms of bleeding, anemia, renal issues: clinical evaluation
Advanced users typically integrate vitamin C with:
- Comprehensive antioxidant stack (NAC, glutathione precursors, alpha-lipoic acid, CoQ10)
- Mitochondrial support (CoQ10, PQQ, creatine)
- Foundational micronutrients (D3, K2, magnesium, zinc, B-complex)
- Condition-specific adjuncts per indication
Cost at advanced level: $25-60/month for oral vitamin C components; IV vitamin C is $150-300 per infusion in most integrative clinics; total integrated stack $100-300/month depending on breadth.
Advanced protocols beyond simple oral supplementation should be undertaken with clinician awareness, especially for IV administration, which requires pre-treatment G6PD and renal screening and clinic supervision.
Commonly Stacked With
Vitamin C stacks effectively with numerous foundational compounds. The key interactions are described below, organized by relevance and evidence strength.
Collagen peptides and glycine (connective tissue synergy): This is one of the most practically useful stacks. Collagen peptides (10-15 g) taken with vitamin C (50-100 mg) prior to tendon/ligament-loading exercise has been shown by Shaw et al.to roughly double collagen synthesis markers compared to collagen alone. Adding glycine (3-5 g) further supports collagen residue availability (since glycine is the most abundant amino acid in collagen—see /compound/glycine). The collagen + glycine + vitamin C stack is the evidence-based approach for tendon/ligament health, post-injury recovery, and skin/connective tissue support.
Iron supplements (non-heme iron absorption enhancement): Vitamin C in the intestinal lumen enhances non-heme iron absorption by 2-4× via reduction of Fe³⁺ to Fe²⁺. This is the classic pairing for iron-deficiency anemia: ferrous sulfate 65 mg (or equivalent) + vitamin C 100-200 mg with a meal. Note: recent research (Li et al.) has questioned whether vitamin C enhancement is as clinically meaningful for newer iron formulations; for classic ferrous sulfate the effect remains robust. Vegetarians and vegans should routinely consume vitamin C-rich foods with iron-rich plant foods (spinach + citrus dressing, lentils + red pepper, etc.). Do not take vitamin C with non-supplemental iron if you have hemochromatosis or iron overload.
Vitamin E (tocopherol regeneration): Vitamin C regenerates α-tocopherol from its oxidized radical form, enabling continued vitamin E antioxidant activity. The in vitro synergy is well-established. Clinical trials of combined C+E supplementation have been disappointing for cardiovascular endpoints (HOPE-TOO, Physicians' Health Study II), reflecting complexities of antioxidant network biology, but the mechanistic synergy remains valid for mixed-antioxidant dietary patterns. Supplementation of both at modest doses (vitamin C 200-500 mg + vitamin E 100-400 IU mixed tocopherols) is reasonable but not clearly advantaged over single-component or food-based approaches.
Glutathione and N-acetylcysteine (NAC): Vitamin C and glutathione operate as intersecting nodes in the antioxidant network. NAC provides cysteine for glutathione synthesis; vitamin C supports recycling of oxidized glutathione and regenerates dehydroascorbate back to ascorbate via glutathione-dependent reductase. Practical stack for antioxidant-focused support: vitamin C 500 mg AM + NAC 600-1,200 mg daily. See /compound/nac and /compound/glutathione.
Zinc (immune synergy): The classic cold-and-flu pairing. Zinc lozenges and zinc picolinate 15-30 mg daily, plus vitamin C 500-1,000 mg daily, is widely used during cold/flu season. Evidence base for the combination specifically is weaker than for each alone, but the biological logic (both support immune function, both are commonly deficient) is sound. See /compound/zinc.
Quercetin (flavonoid co-factor): Quercetin is a plant flavonoid with antiviral and antioxidant effects; it may synergize with vitamin C in immune contexts. Vitamin C 500 mg + quercetin 250-500 mg is a common immune-support pairing with modest supporting evidence. Both are found together in foods (onions, apples, citrus peel).
Bioflavonoids (rutin, hesperidin, citrus flavonoids): Traditional "vitamin P" combinations; bioflavonoids may stabilize vitamin C and support microvascular integrity. Evidence for meaningful clinical advantage of flavonoid-containing vitamin C products over plain ascorbic acid is limited but not zero. Whole-food sources deliver this combination naturally.
Vitamin D and vitamin K2: No direct antagonism or synergy with vitamin C specifically, but all are components of a comprehensive foundational stack. Take D3+K2 with breakfast (fat-containing meal for absorption) and vitamin C any time—they don't compete. See /compound/vitamin-d and /compound/vitamin-k2.
Magnesium: No direct interaction with vitamin C. Magnesium ascorbate is a buffered form delivering both; reasonable option for those tolerating magnesium well but wanting less acidic vitamin C. See /compound/magnesium.
Turmeric/curcumin: Complementary antioxidant and anti-inflammatory effects. No interaction; can be stacked. See /compound/curcumin.
Creatine: No interaction; creatine 3-5 g/day and vitamin C are commonly stacked without concern. See /compound/creatine.
Carnitine and acetyl-L-carnitine: Vitamin C is required for carnitine biosynthesis; adequate vitamin C status supports optimal carnitine levels. Not a direct same-time-same-dose synergy, but functional.
Coffee and tea: Polyphenols in coffee and tea can inhibit non-heme iron absorption, partially reversed by vitamin C co-consumption. Practical meal strategy: for iron-dependent meals (lentils, spinach), take vitamin C-rich food (orange, red pepper) and avoid coffee/tea for 1-2 hours after.
Alcohol: Chronic alcohol use depletes vitamin C via multiple mechanisms (reduced intake from diet displacement, increased oxidative stress, impaired absorption). Chronic drinkers have much higher prevalence of subclinical deficiency and benefit from routine supplementation.
Smoking: Tobacco smoke imposes large oxidative stress; smokers have lower plasma vitamin C at equivalent intake. RDA adds 35 mg/day for smokers; practical supplementation at 200-500 mg/day is reasonable.
Aspirin (chronic low-dose): Long-term aspirin can reduce plasma vitamin C modestly; clinical significance minor but supports ensuring adequate intake.
Stacks to avoid or manage:
- High-dose vitamin C + chemotherapy or radiation (context-dependent): coordinate with oncology team.
- High-dose vitamin C + iron supplementation in hemochromatosis: avoid.
- High-dose vitamin C + warfarin: pharmacokinetic interactions are minimal, but reports exist of vitamin C altering warfarin effect; monitor INR if initiating high-dose vitamin C in a warfarin patient.
- High-dose vitamin C + aluminum-containing antacids: vitamin C may increase aluminum absorption; minor concern for chronic co-use.
- Chronic gram-level vitamin C + intense exercise training: may blunt training adaptations; use lower doses during key training blocks.
Timing:
- Divided doses: because oral absorption saturates, splitting 1,000 mg daily across 2-3 doses maintains plasma levels more effectively than a single 1,000 mg dose.
- With meals: improves GI tolerability; no meaningful effect on absorption.
- Morning vs. evening: no strong preference. Some users report mild stimulation at high doses; if that's an issue, dose earlier in the day.
- Pre/post workout: avoid large doses immediately before or after training if training adaptation is the priority (see exercise adaptation note).
Ideal foundational stack example:
- AM: vitamin C 250-500 mg + D3 + K2 + B-complex + magnesium glycinate (or evening)
- Midday: vitamin C 250 mg (if doing split dosing above 500 mg daily total)
- PM: magnesium, glycine, other evening supplements
In summary, vitamin C is one of the easiest compounds to integrate into any stack. The most useful specific pairings are with collagen/glycine for connective tissue, with iron for absorption enhancement, with zinc for immune support, and with the broader antioxidant network (glutathione, NAC, vitamin E) for oxidative stress management.
Side Effects & Safety
Contraindications
**Absolute contraindications:** - **Hereditary hemochromatosis with iron overload:** vitamin C enhances iron absorption and reduces Fe³⁺ to Fe²⁺, worsening iron overload and potentially contributing to organ damage (heart, liver, pancreas). These patients should limit vitamin C to RDA levels (90 mg) from food or modest supplements and avoid high-dose supplementation. - **Thalassemia major and other iron-overload states requiring chronic transfusion:** same concern as hemochromatosis. Discuss any supplementation with hematology. - **Severe oxalate kidney stone history with ongoing stone risk:** high-dose chronic vitamin C (>1 g/day) can increase oxalate stone risk. Limit to ≤500 mg daily and hydrate well. - **Severe G6PD deficiency receiving IV vitamin C:** risk of oxidative hemolysis at pharmacologic IV doses. Oral supplementation at typical doses is safer but should still be discussed with hematology. **Relative contraindications / caution:** - **Active chemotherapy or radiation therapy:** context-dependent interaction with treatment efficacy and toxicity. Coordinate with oncology team before starting or continuing vitamin C supplementation. - **Chronic kidney disease (eGFR <60 mL/min/1.73m²):** limit to ≤500 mg/day supplemental; risk of hyperoxaluria with higher doses. - **Dialysis patients:** vitamin C is not well-cleared by dialysis; some centers recommend specific supplementation, others restrict. Follow nephrology team guidance. - **Calcium oxalate kidney stone history (any severity):** limit to ≤500 mg daily; emphasize dietary sources; hydrate to maintain dilute urine. - **Active gastric ulcer or severe GERD:** acidic ascorbic acid may aggravate; use buffered form (sodium/calcium/magnesium ascorbate). - **Chronic high-dose NSAID use with GI concerns:** similar caution; buffered form preferred. - **Smoker pursuing maximum training adaptation:** chronic gram-level vitamin C may blunt exercise adaptation (Ristow/Paulsen). Consider lower doses during key training blocks. - **Hyperoxaluria (primary or secondary):** avoid high-dose vitamin C. **Drug interactions:** - **Warfarin:** can modestly reduce INR at high doses; monitor if initiating high-dose vitamin C in a warfarin patient. Coordinate with anticoagulation clinic. - **Aluminum-containing antacids:** vitamin C can increase aluminum absorption; minor concern with chronic co-use. - **Cyclosporine:** vitamin C may reduce cyclosporine levels theoretically; monitor if using both. - **Estrogen/oral contraceptives:** vitamin C may modestly increase estrogen levels in some studies; clinical significance minor. - **Iron supplements:** enhancement of absorption; clinically beneficial in iron deficiency, harmful in iron overload. - **Chemotherapy agents:** context-dependent; coordinate with oncology. - **Chelation therapy (EDTA, desferrioxamine):** interactions possible; coordinate with clinician. - **Aspirin:** chronic aspirin reduces plasma vitamin C modestly; ensure adequate intake. - **Acetaminophen/paracetamol:** vitamin C may reduce acetaminophen clearance; clinical significance minor. **Populations requiring clinician input before high-dose supplementation:** - Active cancer patients - Hemochromatosis and iron overload disorders - Severe kidney disease - History of recurrent calcium oxalate kidney stones - Warfarin users - Patients on chemotherapy or complex medication regimens - Thalassemia patients **Pediatric specific:** - Oral pediatric supplementation at age-appropriate RDA doses (15-75 mg/day) is safe and sometimes beneficial for children with restrictive diets. - Infant formula and breast milk provide adequate vitamin C; supplementation not routinely needed in healthy infants. - Scurvy in children with severe food selectivity, autism spectrum disorder, or malnutrition—consider in differential diagnosis of unexplained bleeding, irritability, or failure to thrive. - High-dose supplementation (>1 g/day) in children is rarely indicated; discuss with pediatrician if considering. **Pregnancy and lactation:** - RDA: 85 mg/day pregnant, 120 mg/day lactating. - Supplementation up to 200-500 mg daily is generally considered safe. - Very high doses (>2 g/day) in late pregnancy may theoretically predispose newborn to rebound scurvy; rare but has been reported. Moderate intakes avoid this concern. - Standard prenatal vitamins contain 85-120 mg; additional modest supplementation is fine; avoid gram-level supplementation in pregnancy without obstetric guidance. - Vitamin C has been investigated for preeclampsia and preterm birth prevention with largely disappointing results in RCTs; not routinely recommended at high doses for these indications. **Elderly specific:** - Reduced dietary intake and absorption efficiency common in older adults. - Supplementation at 500-1,000 mg daily generally beneficial and safe in absence of renal or iron-overload contraindications. - Polypharmacy screening for drug interactions recommended. **Overdose:** - Acute oral overdose: severe osmotic diarrhea, abdominal cramping, nausea; self-limiting and resolves with fluid replacement. - No serious acute oral toxicity reported in case literature. - IV overdose (rare, typically from clinical dosing error): hemolysis in G6PD deficient, possible renal oxalate deposition. - Management: supportive; hydration; monitor renal function. **Pre-operative considerations:** - Routine 500-1,000 mg daily vitamin C does not require discontinuation before most surgeries; may support wound healing. - Very high doses should be reduced to routine levels 1-2 weeks pre-op if high-dose oncology protocols are being used. - Disclose all supplementation to surgical team. **Special considerations for IV vitamin C:** - Mandatory G6PD screening before IV - Renal function assessment - Iron overload screening - Blood pressure monitoring during infusion - Coordination with primary medical team - Not available for self-administration In practical terms, oral vitamin C at conventional doses (up to 1,000 mg/day) is very safe for the overwhelming majority of adults. The meaningful contraindications are iron overload disorders, severe kidney stone history, and specific chemotherapy contexts. The main safety issue for most users is simply GI tolerance of higher doses, easily managed by dose adjustment or form selection.
Additional Notes
Elemental and form considerations:
L-ascorbic acid: The parent compound; cheapest and most abundant. Slightly acidic (pH ~2.5 in solution). Widely available as powder, tablets, capsules. Excellent bioavailability. Can cause stomach upset in sensitive individuals.
Sodium ascorbate: Buffered form; neutral pH (~7). Gentler on stomach; delivers approximately 131 mg elemental sodium per 1,000 mg (relevant for sodium-restricted diets). Equivalent bioavailability to ascorbic acid.
Calcium ascorbate: Buffered; delivers ~90 mg elemental calcium per 1,000 mg. Mild alkaline pH. Good for those with ascorbic acid intolerance who aren't already supplementing calcium heavily.
Magnesium ascorbate: Buffered; delivers modest magnesium. Double-foundational benefit.
Ester-C (calcium ascorbate with ascorbic acid metabolites): Marketed as longer-acting/gentler. Some evidence of enhanced retention in leukocytes; differences at population level modest.
Ascorbyl palmitate (fat-soluble): Primarily used in topical cosmetics and as food antioxidant. Limited oral supplementation role beyond niche uses.
Liposomal vitamin C: Encapsulated in phospholipid liposomes. Marketed for enhanced absorption and higher plasma concentrations at lower oral doses. Evidence for meaningfully superior plasma concentrations versus equivalent oral ascorbic acid is modest (Davis et al.) and product quality varies widely. At substantial price premium; may offer incremental benefit at higher oral doses where standard forms saturate absorption more quickly.
Whole-food concentrates (acerola cherry, camu camu, rose hips): Natural forms delivering vitamin C plus flavonoids and other cofactors. Higher cost per mg of vitamin C. Preferred by users wanting food-matrix delivery.
Target daily intake:
- RDA: 90 mg men, 75 mg women (baseline scurvy prevention)
- Smokers: add 35 mg/day
- Reasonable supplementation for most adults: 200-500 mg daily
- During acute illness or high-stress periods: 1,000-2,000 mg daily (divided doses)
- Bowel tolerance or high-dose protocols: 4-10 g daily during acute illness only, not chronic
- Tolerable Upper Intake Level (UL): 2,000 mg/day (GI tolerance threshold, not toxicity)
Absorption pharmacokinetics:
- Single oral doses <200 mg: >80% absorbed
- 200-500 mg: 60-75% absorbed; plasma rises meaningfully
- 500-1,000 mg: 50-60% absorbed; plasma plateau approaching
- 1,000-1,250 mg: plasma concentration plateaus around 80 μmol/L
-
1,250 mg single dose: minimal additional plasma rise; excess excreted in urine
- Divided doses improve total absorption; e.g., 1,000 mg split as 4×250 mg yields higher total plasma AUC than single 1,000 mg
Timing:
- With meals: improves tolerability; no meaningful effect on absorption
- Split dosing (2-3×/day) preferable for total daily intakes above 500 mg
- Morning or afternoon: no strong preference; avoid immediate pre-bed for those sensitive to mild alerting effect
- Avoid within 1-2 hours of iron supplements in hemochromatosis
- Avoid large acute doses immediately pre-/post-exercise if training adaptation priority
Time to biological effect:
- Plasma saturation: 1-3 days at 500+ mg/day
- Tissue repletion: 1-4 weeks
- Scurvy resolution: days to weeks at 300 mg+/day
- Collagen synthesis markers: hours to days
- Immune cell ascorbate: days
- Common cold duration: effects during the illness itself
Cycling: Not required. Vitamin C is intended for continuous daily intake. No known downregulation; body maintains ascorbate homeostasis regardless of intake.
Measurement:
- Plasma ascorbate: reference 23-114 μmol/L; optimal >50 μmol/L. Not routine but available.
- Leukocyte ascorbate: reflects tissue stores; less commonly measured.
- Scurvy-specific symptoms: when present, diagnostic.
Most users do not require measurement; empirical 200-500 mg daily is safe and effective for general use. Measurement informative in suspected deficiency, for high-dose protocols, or in specific research contexts.
Interactions with diagnostic tests:
- Urine glucose (dipstick): false-negative at high doses
- Point-of-care blood glucose (glucose oxidase): false-positive at high doses
- Stool occult blood: false-negative at high doses (can mask GI bleeding)
- LDL cholesterol (some assays): small effect
- Urinary oxalate: increased at high doses
- Hold high-dose vitamin C 24-48 hours before relevant testing
Typical product landscape:
- Plain ascorbic acid powder: $5-15/month for 1 g/day
- Buffered ascorbate capsules: $10-20/month
- Ester-C: $15-25/month
- Liposomal: $30-60/month (sometimes higher)
- Whole-food concentrates: $20-40/month
- IV vitamin C infusion: $150-300/session in integrative clinics
In summary, for the vast majority of adults, plain ascorbic acid or buffered ascorbate at 500 mg daily in divided doses is the practical, cost-effective, evidence-based default. Higher doses serve specific indications; form upgrades (liposomal, Ester-C) offer marginal benefits at substantially higher cost.
Frequently Asked Questions
What is the recommended Vitamin C dosage?
Dosage for Vitamin C varies by protocol. Consult a qualified healthcare provider.
How often should I take Vitamin C?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Vitamin C need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Vitamin C side effects?
Vitamin C has an excellent safety profile at typical supplementation doses (200-1,000 mg daily). Serious adverse effects are rare and are largely limited to specific clinical scenarios. The vitamin's water solubility, regulated absorption, and renal excretion contribute to a wide therapeutic margin. **Common side effects at high oral doses:** - **Gastrointestinal upset:** nausea, heartburn, abdominal cramping, osmotic diarrhea. These emerge typically above 2,000 mg daily, especially when taken as ascorbic acid (vs. mineral ascorbate buffered forms). Dose-dependent; resolves with dose reduction or switching to buffered form or esterified form. - **Flushing:** rare; possibly due to histamine release. - **Dental erosion (from chewable ascorbic acid tablets):** the acidic pH can erode enamel with chronic use. Avoid chewable acidic forms for daily use; if chewables are used, rinse mouth with water afterward. **Kidney stone risk.** Vitamin C is metabolized in part to oxalate, which combines with calcium in the urinary tract to form calcium oxalate stones. High-dose chronic vitamin C supplementation (>1,000 mg/day) modestly increases urinary oxalate excretion and may increase kidney stone risk, particularly in men and in individuals with prior history of calcium oxalate stones or other risk factors. Thomas et al. (PMID 23381591) found a 43% increased risk of kidney stones in men taking ≥1,000 mg/day versus non-users in the Cohort of Swedish Men. Women appear less susceptible in most studies. Practical guidance: individuals with a history of calcium oxalate kidney stones should limit vitamin C to ≤500 mg daily, hydrate well, and discuss with their nephrologist or urologist. Buffered ascorbate forms (calcium, magnesium, sodium ascorbate) are not clearly advantaged over ascorbic acid for stone risk; total oxalate production is similar. **Iron overload potentiation.** Vitamin C enhances non-heme iron absorption and also reduces Fe³⁺ to Fe²⁺. In patients with hereditary hemochromatosis (HFE mutations), thalassemia major, or transfusion-dependent anemia, high-dose vitamin C supplementation can worsen iron overload and contribute to organ damage. Such patients should not take vitamin C supplements above RDA doses and should discuss with their hematologist. Vitamin C from food is not restricted unless supplementation levels are being exceeded. **G6PD deficiency hemolysis (at very high doses).** Glucose-6-phosphate dehydrogenase deficiency is the most common enzyme deficiency worldwide, particularly among individuals of African, Mediterranean, and Asian descent. At very high doses—typically IV vitamin C at gram levels, rarely at oral gram doses—vitamin C can precipitate hemolysis in G6PD-deficient individuals via oxidative stress overwhelming residual antioxidant capacity. This is a specific concern for IV vitamin C protocols, which should test G6PD status before initiating. Oral doses ≤2 g daily are generally considered safe even in G6PD deficiency, but dose-dependent risk exists. **Interference with laboratory tests.** High-dose vitamin C can cause false-negative urine glucose dipstick results and false-positive blood glucose readings on some point-of-care meters (glucose oxidase-based). It can also interfere with stool occult blood testing, producing false-negative results and masking GI bleeding. Patients undergoing relevant testing should disclose vitamin C supplementation and hold doses for 24-48 hours before testing if feasible. **Exercise adaptation blunting.** Chronic high-dose vitamin C supplementation (≥1 g daily) during training periods may reduce exercise-induced mitochondrial biogenesis and other adaptive responses by scavenging the reactive oxygen species that drive these adaptations (Ristow et al.; Paulsen et al.). Athletes pursuing peak adaptation should avoid chronic gram-level vitamin C dosing during key training blocks. Standard dietary intake or modest 200-500 mg/day does not appear to interfere meaningfully. **Interactions with cancer chemotherapy.** Theoretical concerns exist about vitamin C (particularly IV) interacting with chemotherapy—either enhancing or interfering with cytotoxic effects depending on the agent and context. Patients undergoing active chemotherapy should discuss vitamin C supplementation with their oncology team before initiating or continuing; the field has moved from general prohibition to nuanced context-dependent recommendations, but individual coordination is essential. **Copper overload/Wilson disease:** Not a direct contraindication, but theoretical interaction with copper metabolism. Most Wilson disease patients do not need to restrict vitamin C specifically beyond their overall dietary copper management plan. **Allergic reactions.** True allergy to ascorbic acid is very rare. More common: reaction to tablet excipients or capsule fillers. Switching to a cleaner product or pure ascorbic acid powder usually resolves. **Population-specific considerations:** *Pregnancy and lactation:* Vitamin C at RDA doses (85 mg/day pregnant, 120 mg/day lactating) is safe. Supplementation up to 200-500 mg daily is generally considered safe. Very high doses (>2,000 mg/day) during late pregnancy have been associated with rebound scurvy in the newborn (the infant adapted to high maternal levels then drops to typical intake after birth), though this is rare. Stay within moderate supplementation ranges during pregnancy. *Children:* Pediatric RDAs are age-scaled (15-45 mg/day for ages 1-13). Childhood scurvy still occurs, especially in children with severe food selectivity, autism spectrum disorder, or malnutrition; awareness of this is important. Routine high-dose supplementation is not recommended for most children; dose is adjusted to age and indication. *Elderly:* Higher baseline rates of subclinical deficiency due to reduced fruit/vegetable intake, polypharmacy, and reduced absorption efficiency. Supplementation at 100-500 mg daily is reasonable for many older adults. *Smokers:* Tobacco smoke depletes vitamin C via oxidative stress; RDA includes an additional 35 mg/day for smokers. Supplementation at 200-500 mg daily is reasonable. *Diabetics:* Vitamin C modestly improves endothelial function and glycemic markers in diabetic populations. Supplementation at standard doses is generally beneficial. Be aware of glucose test interference at gram-level doses. *Renal insufficiency:* In chronic kidney disease, decreased renal clearance may raise plasma oxalate; limit supplementation to ≤500 mg/day and coordinate with nephrology. *Thalassemia/hemochromatosis:* Limit to RDA doses; do not take high-dose vitamin C. **Tolerable Upper Intake Level (UL):** The U.S. Institute of Medicine sets the UL at 2,000 mg/day for adults, based on the risk of osmotic diarrhea and gastrointestinal discomfort. This is a GI-tolerability threshold, not a toxicity threshold; short-term excursions are generally safe, but chronic exceedance increases kidney stone risk in susceptible populations. **Overdose:** Accidental ingestion of gram-quantities of vitamin C has not produced serious toxicity in case reports. Management is supportive. Extreme acute doses produce severe osmotic diarrhea and possibly vomiting; these are self-limiting and resolve with fluid replacement. In summary, vitamin C is very safe at conventional supplementation doses. The main dose-dependent concerns are GI intolerance above 2 g/day, modest kidney stone risk at chronic gram-plus doses especially in men with stone history, iron overload potentiation in hemochromatosis/thalassemia, and potential exercise adaptation interference in athletes at chronic high doses. For most healthy adults, 200-1,000 mg daily is well within the safety margin and poses minimal risk.
Where can I buy Vitamin C?
Visit our vendor directory to find trusted sources for Vitamin C.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
